Ownership history in UBS Group AG · 15 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in SENSEI BIOTHERAPEUTICS INC (SNSE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 873 | -1,267 | -59.2% | 0.00% | $8K | $9.45 |
| 2025 Q2 | REDUCED | 2,140 | -40,401 | -95.0% | 0.00% | $18K | $8.58 |
| 2025 Q1 | ADDED | 42,541 | +42,539 | +2126950.0% | 0.00% | $17K | $7.88 |
| 2024 Q4 | REDUCED | 2 | -137 | -98.6% | 0.00% | $1 | $9.80 |
| 2024 Q1 | REDUCED | 139 | -6,372 | -97.9% | 0.00% | $146 | $21.00 |
| 2023 Q2 | ADDED | 6,511 | +3,071 | +89.3% | 0.00% | $7K | $22.80 |
| 2023 Q1 | ADDED | 3,440 | +2,343 | +213.6% | 0.00% | $5K | $30.00 |
| 2022 Q4 | REDUCED | 1,097 | -12,017 | -91.6% | 0.00% | $2K | $29.80 |
| 2022 Q3 | REDUCED | 13,114 | -349 | -2.6% | 0.00% | $20K | $31.00 |
| 2022 Q2 | REDUCED | 13,463 | -155 | -1.1% | 0.00% | $31K | $45.40 |
As of 2025 Q4 — sorted by position size